SCHEMBL27496175

SCHEMBL27496175

CS(=O)(=O)c1ccnc(N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 4/20 0.48
▸ NOS2 P35228 4/20 0.48
▸ NOS1 P29475 3/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ ROCK1 Q13464 2/20 0.45
▸ G6PD P11413 1/20 0.44
▸ IDE P14735 1/20 0.44
▸ GABRP O00591 2/20 0.42
▸ GABRD O14764 2/20 0.42
▸ GABRA1 P14867 2/20 0.42
▸ GABRB1 P18505 2/20 0.42
▸ GABRG2 P18507 2/20 0.42
▸ GABRB3 P28472 2/20 0.42
▸ GABRA5 P31644 2/20 0.42
▸ GABRA3 P34903 2/20 0.42
▸ GABRA2 P47869 2/20 0.42
▸ GABRB2 P47870 2/20 0.42
▸ GABRA4 P48169 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27673210 0.79 KDM4E (0.52) NOS3NOS2NOS1KDM4EMEN1
SCHEMBL13801171 0.77 UHRF1 (0.48) ROCK1G6PDIDE
SCHEMBL10920036 0.77 ROCK1 (0.40) ROCK1G6PDIDE
SCHEMBL6883165 0.75 PTGS2 (0.46) ROCK1LOXL2
SCHEMBL31599666 0.75 PTGS1 (0.39) ROCK1G6PDIDE
SCHEMBL30700822 0.75 PTGS2 (0.46) ROCK1LOXL2
SCHEMBL16289399 0.75 ROCK1 (0.39) ROCK1G6PDIDE
SCHEMBL1403910 0.75 PTGS1 (0.39) ROCK1G6PDIDE
SCHEMBL5252690 0.75 NOS3 (0.40) NOS3NOS2NOS1KDM4EMEN1
SCHEMBL13727819 0.75 ALDH1A1 (0.55) NOS3NOS2NOS1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4347032-A1 SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS Vertex Pharmaceuticals Incorporated (US) 2024-04-10 — — EP disclosed
WO-2022256702-A1 SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-12-08 — — WO disclosed
CN-1171788-A Therapeutic agent for osteoporosis and triaza * compound JAPAN TOBACCO INC (JP) 1998-01-28 — — CN disclosed
Send feedback